Polyclonal versus monoclonal immunoglobulin-free light chains quantification.
Giuseppe Di Noto1, Elena Cimpoies1, Alessandra Dossi1
1Department of Molecular and Translational Medicine, Faculty of Medicine, University of Brescia, Italy.
Annals of Clinical Biochemistry
|September 17, 2014
Summary
Serum free light chain assays, Freelite™ and N Latex, show varying accuracy for monoclonal proteins. Dimeric free light chains can impact quantification, affecting clinical interpretation in conditions like plasma cell dyscrasia.
Area of Science:
- Clinical chemistry
- Immunology
- Protein analysis
Background:
- Serum free light chain (sFLC) assays have growing clinical utility beyond plasma cell dyscrasias.
- Two certified methods, Freelite™ and N Latex, are available for sFLC quantification.
- Investigating assay performance with different sFLC structures is crucial.
Purpose of the Study:
- To compare the quantification of serum free light chains using Freelite™ and N Latex assays.
- To assess the impact of sFLC concentration and structure on assay results.
- To evaluate assay performance in samples with and without monoclonal components.
Main Methods:
- Analysis of 524 patient serum samples using Freelite™ and N Latex assays.
- Comparison of results in subgroups with and without monoclonal components.
- Investigation of dimeric and monomeric sFLC forms using SDS-PAGE and densitometry.
Main Results:
- High correlation for polyclonal kappa (κ) and lambda (λ) sFLCs (r=0.90-0.91).
- Lower correlation for monoclonal κ and λ sFLCs, especially at high concentrations (r=0.82, r=0.56).
- Assays do not accurately reflect protein mass for monoclonal sFLCs, influenced by dimerization.
Conclusions:
- Quantification of high-concentration monoclonal sFLCs may differ from polyclonal sFLCs.
- sFLC dimerization affects assay accuracy due to altered scattering properties.
- Clinical interpretation requires awareness of assay limitations with specific sFLC structures.
